Q32 Bio Inc.
QTTB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | -$6,651 | $6,651 | $33,971 |
| % Growth | 100% | -200% | -80.4% | – |
| Cost of Goods Sold | $487 | $0 | $0 | $9,544 |
| Gross Profit | -$487 | -$6,651 | $6,651 | $24,427 |
| % Margin | – | 100% | 100% | 71.9% |
| R&D Expenses | $48,143 | $31,729 | $35,814 | $93,085 |
| G&A Expenses | $0 | $9,875 | $10,062 | $0 |
| SG&A Expenses | $17,472 | $9,875 | $10,062 | $27,291 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $65,615 | $41,604 | $45,876 | $120,376 |
| Operating Income | -$66,102 | -$48,255 | -$39,225 | -$95,949 |
| % Margin | – | 725.5% | -589.8% | -282.4% |
| Other Income/Exp. Net | $18,390 | -$5,170 | -$3,522 | $185 |
| Pre-Tax Income | -$47,712 | -$53,425 | -$42,747 | -$95,764 |
| Tax Expense | $21 | $318 | $62 | $0 |
| Net Income | -$47,733 | -$53,743 | -$42,809 | -$95,764 |
| % Margin | – | 808% | -643.6% | -281.9% |
| EPS | -5.12 | -16.7 | -13.42 | -12.23 |
| % Growth | 69.3% | -24.4% | -9.7% | – |
| EPS Diluted | -6.58 | -16.7 | -13.42 | -12.23 |
| Weighted Avg Shares Out | 12,198 | 3,219 | 3,189 | 3,071 |
| Weighted Avg Shares Out Dil | 12,198 | 3,219 | 3,189 | 3,071 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,900 | $0 | $0 | $0 |
| Interest Expense | $300 | $0 | $0 | $0 |
| Depreciation & Amortization | $487 | $499 | $370 | $9,544 |
| EBITDA | -$45,300 | -$47,756 | -$38,855 | -$86,220 |
| % Margin | – | 718% | -584.2% | -253.8% |